#breast cancer — Thursday, August 06, 2026 (2 items)
| 0 | 💬 0 |
Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2-breast cancer: A randomized, phase 2 trial FASCINATE-N.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-08-06 | #breast cancer #precision medicine #neoadjuvant #classification #subtyping | |
| 0 | 💬 0 |
Biomarker-guided responses in patient-derived organoids predict effective therapies in breast cancer.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-08-06 | #breast cancer #organoid #biomarker #precision medicine #drug resistance |